Related Experiment Video

Updated: Aug 11, 2026

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection
11:14

Detection of Low Copy Number Integrated Viral DNA Formed by In Vitro Hepatitis B Infection

Published on: November 7, 2018

Chronic hepatitis C: T-helper1/T-helper2 imbalance could cause virus persistence in peripheral blood

N Osna1, G Silonova, N Vilgert

  • 1Institute of Immunology, Latvian Medical Academy, Riga, Latvia.

Scandinavian Journal of Clinical and Laboratory Investigation
|February 12, 1998
PubMed

Insights

Chronic hepatitis C patients show reduced interferon gamma (IFN gamma) production. This deficiency is linked to elevated interleukin-10 (IL-10) levels and impaired IL-12 production, suggesting a complex immune dysregulation in CHC.

Area of Science:

  • Immunology
  • Virology
  • Hepatology

Background:

  • Chronic hepatitis C (CHC) is a significant global health concern.
  • Immune dysregulation plays a crucial role in the pathogenesis of CHC.
  • Understanding cytokine profiles in CHC is vital for therapeutic strategies.

Purpose of the Study:

  • To investigate the production of key cytokines, including interferon gamma (IFN gamma) and interleukins (IL-4, IL-10, IL-12), in patients with CHC.
  • To elucidate the relationship between these cytokines and the observed deficiency in IFN gamma response in CHC.
  • To explore the potential roles of IL-10 and IL-12 in modulating IFN gamma production in CHC.

Main Methods:

  • Measurement of IFN gamma, IL-4, IL-10, and IL-12 in whole peripheral blood (WPB) and peripheral blood mononuclear cells (PBMC) from 10 CHC patients.
  • Comparison of cytokine levels in CHC patients with healthy donors.
  • Assessment of IL-10's effect on IFN gamma by neutralization experiments.
  • Evaluation of recombinant IL-12 (rIL-12) effects on IFN gamma production.

Main Results:

  • Mitogen-activated WPB from CHC patients exhibited lower IFN gamma levels compared to healthy donors.
  • Spontaneous IL-10 production was elevated in CHC patients, suggesting its role as a downregulative factor for IFN gamma.
  • Neutralization of IL-10 partially restored IFN gamma response in CHC patients.
  • While rIL-12 enhanced IFN gamma in CHC patients, endogenous IL-12 production was found to be decreased in these patients.
  • IFN gamma deficiency in CHC appears secondary to IL-10-mediated blockage and impaired IL-12 production.

Conclusions:

  • IFN gamma production is significantly impaired in CHC patients.
  • Elevated IL-10 levels and suppressed IL-12 production contribute to the IFN gamma deficiency observed in CHC.
  • These findings highlight a complex interplay of cytokines in CHC immune pathology and suggest potential therapeutic targets.

More Related Videos

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix10:37

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...